Related Experiment Video
Updated: Jun 8, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 3: evidence
Laia Oliveras1, Benjamin Lazarus2, Amara Sarwal3
1Department of Nephrology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Abstract:
In this part of the Methods Series, we describe how Kidney Disease: Improving Global Outcomes (KDIGO) guidelines move from a defined scope of work to evidence synthesis that will later translate into guideline statements. We review how key questions are defined, outcomes prioritized, and evidence identified and selected. We also outline how evidence is synthesized using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology and how guidelines can contribute to the generation of new evidence. This paper highlights frequently asked questions from KDIGO guideline users and illustrates unique aspects of how KDIGO applies agreed-upon best practices that ensure methodological rigor in guideline development.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Clinical Trials: Overview
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...